<DOC>
	<DOCNO>NCT00887328</DOCNO>
	<brief_summary>The primary hypothesis test trial ischaemic stroke patient select significant penumbral mismatch ( measure MRI criterion ) 3 - 9 hour post onset stroke improve clinical outcome give intravenous tissue plasminogen activator ( tPA ) compare placebo .</brief_summary>
	<brief_title>Extending Time Thrombolysis Emergency Neurological Deficits</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>1 . Patients present acute ischaemic stroke 2 . Patient , family member legally responsible person depend local ethic requirement give informed consent 3 . Patient 's age ≥18 year 4 . Treatment onset commence within ≥ 3 9 hour stroke onset accord registered product information , within 4.5 9 hour accord locally accept guidelines* . ( *Guidelines currently international review advisory statement issue Stroke Council , American Heart Association American Stroke Association ) 5 . Patients wake stroke may include neurological exclusion criterion satisfy . These 'wake ' stroke define symptom sleep onset , stroke symptom wake . The time stroke onset take midpoint sleep onset ( last know normal ) time wake . The maximum time window randomisation 9 hour midpoint describe . 6 . NIHSS score ≥ 4 26 clinical sign hemispheric infarction . 7 . Penumbral imaging** Using Tmax &gt; 6 second delay , perfusion ( PWI ) lesion volume diffusion ( DWI ) lesion volume ratio &gt; 1.2 , DWI volume ≤70mL PWIDWI difference &gt; 10 ml . Patients may consent penumbral screen depend upon local practice . The entire cohort patient consent onto study follow clinical assessment biomarker study regardless eligibility randomisation treatment base penumbral mismatch criterion 1 . Intracranial haemorrhage ( ICH ) identify CT MRI 2 . Rapidly improve symptom , particularly judgment manage clinician improvement likely result patient NIHSS score &lt; 4 randomization 3 . Prestroke MRS score ≥ 2 ( indicate previous disability ) 4 . Contra indication image MR contrast agent 5 . Infarct core &gt; 1/3 MCA territory qualitatively 6 . Participation investigational study previous 30 day 7 . Any terminal illness patient would expect survive 1 year 8 . Any condition could impose hazard patient study therapy initiate affect participation patient study ( applies patient severe microangiopathy haemolytic uremic syndrome thrombotic thrombocytopenic purpura ) . The judgment leave discretion Investigator . 9 . Pregnant woman ( clinically evident ) 10 . Previous stroke within last three month 11 . Recent past history clinical presentation ICH , subarachnoid haemorrhage ( SAH ) , arteriovenous ( AV ) malformation , aneurysm , cerebral neoplasm . At discretion Investigator . 12 . Current use oral anticoagulant prolong prothrombin time ( INR &gt; 1.6 ) 13 . Use heparin , except low dose subcutaneous heparin , previous 48 hour activate prolonged partial thromboplastin time exceed upper limit local laboratory normal range . 14 . Use glycoprotein IIb IIIa inhibitor within past 72 hour . Use single dual agent oral platelet inhibitor ( clopidogrel and/or lowdose aspirin ) prior study entry permit . 15 . Clinically significant hypoglycaemia . 16 . Uncontrolled hypertension define blood pressure &gt; 185 mmHg systolic &gt; 110 mmHg diastolic least 2 separate occasion least 10 minute apart , require aggressive treatment reduce blood pressure within limit . The definition `` aggressive treatment '' leave discretion responsible Investigator . 17 . Hereditary acquire haemorrhagic diathesis 18 . Gastrointestinal urinary bleeding within precede 21 day 19 . Major surgery within precede 14 day pose risk opinion investigator . 20 . Exposure thrombolytic agent within previous 72 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>ischemic stroke</keyword>
	<keyword>ischemic penumbra</keyword>
	<keyword>magnetic resonance imaging</keyword>
	<keyword>MRI</keyword>
	<keyword>diffusion image</keyword>
	<keyword>DWI</keyword>
	<keyword>perfusion image</keyword>
	<keyword>PWI</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>alteplase</keyword>
	<keyword>tPA</keyword>
	<keyword>EPITHET</keyword>
</DOC>